Author: zakaria
-
Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!
Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first line ARVs? GNP+ invites you to an important treatment access discussion on accelerating the roll out of Dolutegravir, a groundbreaking alternative…
-
ITPC-MENA at the launch of the new report on human rights and HIV in Africa by the African Commission on Human and Peoples’ Rights
African Commission on Human and Peoples’ Rights to launch report on human rights and HIV in Africa ‘HIV, the Law and Human Rights in the African Human Rights System: Key Challenges and Opportunities for Rights-based Responses to HIV’ to be launched on the side-lines of the African Union Summit Protecting the human rights of people…
-
New Study : Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
Title: A tool to assess how friendly to access-to-medicines your law is Background Provisions of intellectual property (IP) may have an important impact on access to medicines. For instance, the monopoly granted by the patent prevents competition with generics on the market and is often responsible for high prices. Along the years, IP provisions grow…
-
ITPC-MENA organize its Middle East and North Africa Community Advisory board (MENACAB)
The International Treatment Preparedness Coalition in Middle East and North Africa (ITPC-MENA) is organizing its Middle East and North Africa Community Advisory board (MENACAB), in late November in Marrakech.The MENACAB is a treatment advocate network which main aim is to improve access to strategic information for people living with HIV, Hepatitis B, hepatitis C and tuberculosis…
-
ITPC-MENA at the Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017)
ITPC-MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) Join ITPC-MENA at AFRAMED 2017 – Hammamet Join ITPC_MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) in Tunis and Hammamet from 27 – 30 September 2017. We are co-hosting and participating in many sessions. Check out our flyer below for our full…
-
Job offer for the MENA regional platform manager on Global Fund and Civil Society
JOB DESCRIPTION: REGIONAL GLOBAL FUND PLATFORM MANAGER ABOUT ITPC-MENA: International Treatment Preparedness Coalition (ITPC) Middle East & North Africa (MENA) is a regional non governmental organization operating in the Middle East and North Africa region regrouping a network of community activists united by our vision of a longer, healthier, more productive life for people living…
-
2nd Francophone Symposium AFRAMED on HIV and Hepatitis
2nd Francophone Symposium AFRAMED on HIV and Hepatitis September 28 to 30, Hammamet, Tunisie Following the success of the first experience in Algeria, the second edition of AFRAMED symposium will be hosted by Tunisia. This AFRAMED edition is in line with mobilizations for the success of 90-90-90 goals to put an end at the VIH…
-
IAS 2017: Closing ceremony exposes Gilead Sciences
Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered by Othoman Mellouk, during the closing ceremony, exposed one of the key conference sponsors, Gilead. Mellouk, who is the Intellectual Property…
-
A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt
The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS, which is currently taking place in Paris from the 23rd to 26th July 2017, Bristol-Myers Squibb (BMS) and the Medicines Patent Pool…
-
BLOG: We want dolutegravir for all, and we want it now
Source: makemedicinesaffordable Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to be enacted simultaneously in an initial six countries, in order to get essential treatment to all…